OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo
Wenqi Li, Shuhua Pei, Xiaojing Zhang, et al.
European Journal of Pharmacology (2022) Vol. 922, pp. 174886-174886
Closed Access | Times Cited: 13
Wenqi Li, Shuhua Pei, Xiaojing Zhang, et al.
European Journal of Pharmacology (2022) Vol. 922, pp. 174886-174886
Closed Access | Times Cited: 13
Showing 13 citing articles:
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20
Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
Qi Wang, Juan Liu, Ziye Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116021-116021
Open Access | Times Cited: 11
Qi Wang, Juan Liu, Ziye Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116021-116021
Open Access | Times Cited: 11
Glioma cell membrane camouflaged cinobufotalin delivery system for combinatorial orthotopic glioblastoma therapy
Zibin Song, Liqian Zhao, Weiyi Fang, et al.
Nano Research (2023) Vol. 16, Iss. 8, pp. 11164-11175
Closed Access | Times Cited: 9
Zibin Song, Liqian Zhao, Weiyi Fang, et al.
Nano Research (2023) Vol. 16, Iss. 8, pp. 11164-11175
Closed Access | Times Cited: 9
Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives
Yichao Liao, Feng Wei, Zhelin He, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Yichao Liao, Feng Wei, Zhelin He, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology
Jiyan Wang, Hongkai Chang, Meng Su, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Jiyan Wang, Hongkai Chang, Meng Su, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities
Zixuan Gou, Difei Zhang, Hongliang Cao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Zixuan Gou, Difei Zhang, Hongliang Cao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Cinobufotalin inhibits proliferation, migration and invasion in hepatocellular carcinoma by triggering NOX4/NLRP3/GSDMD-dependent pyroptosis
Chen Liu, Jianmin Wu, Zhiwen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Chen Liu, Jianmin Wu, Zhiwen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells
Yongming Lv, Wenhong Wang, Yanfei Liu, et al.
Clinical & Experimental Metastasis (2023) Vol. 40, Iss. 4, pp. 339-356
Closed Access | Times Cited: 3
Yongming Lv, Wenhong Wang, Yanfei Liu, et al.
Clinical & Experimental Metastasis (2023) Vol. 40, Iss. 4, pp. 339-356
Closed Access | Times Cited: 3
The Wnt signaling pathway in hepatocellular carcinoma: Regulatory mechanisms and therapeutic prospects
Shihui Ma, Guorui Meng, Ying Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117508-117508
Open Access
Shihui Ma, Guorui Meng, Ying Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117508-117508
Open Access
The advancement of structure, bioactivity, mechanism, and synthesis of bufotalin
Nuo Chen, Yunqiang Wu, Huamao Wei, et al.
Steroids (2024), pp. 109555-109555
Closed Access
Nuo Chen, Yunqiang Wu, Huamao Wei, et al.
Steroids (2024), pp. 109555-109555
Closed Access
Cytotoxic and antiproliferative effects of hellebrin on breast and lung cancer cells
Yaşar Şahin, Mustafa Türk, Sedat Sevin, et al.
Veteriner Hekimler Derneği Dergisi (2023) Vol. 94, Iss. 2, pp. 137-143
Open Access | Times Cited: 1
Yaşar Şahin, Mustafa Türk, Sedat Sevin, et al.
Veteriner Hekimler Derneği Dergisi (2023) Vol. 94, Iss. 2, pp. 137-143
Open Access | Times Cited: 1
Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer
Chih-Chieh Tu, Tsung‐Han Hsieh, Cheng‐Ying Chu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access
Chih-Chieh Tu, Tsung‐Han Hsieh, Cheng‐Ying Chu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access
